Whole Genome Sequence of the Rifamycin B-Producing Strain Amycolatopsis mediterranei S699
Author(s) -
Mansi Verma,
Jaspreet Kaur,
Mukesh Kumar,
Kirti Kumari,
Anjali Saxena,
Shailly Anand,
Aeshigam,
Vydianathan Ravi,
Saurabh Raghuvanshi,
Paramjit Khurana,
Akhilesh K. Tyagi,
Jitendra P. Khurana,
Rup Lal
Publication year - 2011
Publication title -
journal of bacteriology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.652
H-Index - 246
eISSN - 1067-8832
pISSN - 0021-9193
DOI - 10.1128/jb.05819-11
Subject(s) - rifamycin , biology , whole genome sequencing , genome , microbiology and biotechnology , antibiotics , sequence (biology) , strain (injury) , genetics , computational biology , gene , anatomy
Amycolatopsis mediterranei S699 is an actinomycete that produces an important antibiotic, rifamycin B. Semisynthetic derivatives of rifamycin B are used for the treatment of tuberculosis, leprosy, and AIDS-related mycobacterial infections. Here, we report the complete genome sequence (10.2 Mb) ofA. mediterranei S699, with 9,575 predicted coding sequences.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom